NOX-2 Inhibitors may be Potential Drug Candidates for the Managementof COVID-19 Complications
Bimalendu Chowdhury(Roland Institute of Pharmaceutical Sciences), Biswajeet Acharya(GITAM University), Amulyaratna Behera(Centurion University of Technology and Management), Korikana Hiramani(Roland Institute of Pharmaceutical Sciences), Biswa Mohan Sahoo(Roland Institute of Pharmaceutical Sciences)
Cited by 6
Related Papers
Optimizing drug discovery: Surface plasmon resonance techniques and their multifaceted applications
|Chemical Physics Impact|2023|97
Carbon quantum dots: A systematic overview of recent developments in synthesis, properties, and novel therapeutic applications
|Inorganic Chemistry Communications|2024|60
Recent Advances in Nanotechnology-Based Drug Delivery Systems for the Diagnosis and Treatment of Reproductive Disorders
|ACS Applied Bio Materials|2024|58
Probiotics: Bridging the interplay of a healthy gut and psychoneurological well‐being
|Food Bioengineering|2024|32
Bamboo shoots: an exploration into its culinary heritage in India and its nutraceutical potential
|Journal of Ethnic Foods|2023|26